Search Results

There are 16018 results for: content related to: Efficacy and Safety of Rizatriptan Versus Standard Care During Long-term Treatment for Migraine

  1. Pharmacokinetic Profile of Rizatriptan 10-mg Tablet and 10-mg Orally Disintegrating Tablet Administered With or Without Water in Healthy Subjects: An Open-Label, Randomized, Single-Dose, 3-Period Crossover Study

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 172–178, Dr Suzanne K. Swan, Dr Harry Alcorn Jr, Mr Anthony Rodgers, Dr Carolyn M. Hustad, Ms Karen E. Ramsey, Ms Susan Woll and Dr Franck Skobieranda

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284194

  2. Pharmacokinetics and Tolerability of Rizatriptan in Pediatric Migraineurs in a Randomized Study

    Headache: The Journal of Head and Face Pain

    Volume 52, Issue 4, April 2012, Pages: 625–635, Iain P. Fraser, Lingling Han, Tae H. Han, Chi-Chung Li, David Hreniuk, S. Aubrey Stoch, John A. Wagner, Steven Linder and Paul Winner

    Version of Record online : 30 JAN 2012, DOI: 10.1111/j.1526-4610.2011.02069.x

  3. Rizatriptan in acute treatment of migraine: update on new comparative data

    Cephalalgia

    Volume 20, Issue s1, November 2000, Pages: 10–15, PJ Goadsby

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1468-2982.2000.020s1010.x

  4. Elimination of Migraine-Associated Nausea in Patients Treated with Rizatriptan Orally Disintegrating Tablet (ODT): A Randomized, Double-Blind, Placebo-Controlled Study

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 3, March 2008, Pages: 368–377, Fred Freitag, Frederick R. Taylor, Mohammed A. Hamid, Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey and Franck Skobieranda

    Version of Record online : 28 NOV 2007, DOI: 10.1111/j.1526-4610.2007.00954.x

  5. Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in Migraine

    Headache: The Journal of Head and Face Pain

    Volume 38, Issue 10, November 1998, Pages: 737–747, Jerome Goldstein, Robert Ryan, Kaihong Jiang, Albert Getson, Barbara Norman, Gilbert A. Block, Christopher Lines and Rizatriptan Protocol 046 Study Group

    Version of Record online : 31 MAY 2002, DOI: 10.1046/j.1526-4610.1998.3810737.x

  6. Rizatriptan, a Novel 5-HT1B/1D Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 40, Issue 1, January 2000, Pages: 74–83, Michael R. Goldberg, Yih Lee, Kamlesh P. Vyas, Donald E. Slaughter, Deborah Panebianco, Susan J. Ermlich, Craig R. Shadle, Mary Jo Brucker, Debra A. McLoughlin and Timothy V. Olah

    Version of Record online : 19 MAR 2013, DOI: 10.1177/009127000004000110

  7. You have free access to this content
    Influence of β-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol

    British Journal of Clinical Pharmacology

    Volume 52, Issue 1, July 2001, Pages: 69–76, Michael R. Goldberg, David Sciberras, Marina De Smet, Richard Lowry, Lisa Tomasko, Yih Lee, Timothy V. Olah, Jamie Zhao, Kamlesh P. Vyas, Rita Halpin, Prasad H. Kari and Ian James

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.0306-5251.2001.01417.x

  8. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine

    Cephalalgia

    Volume 19, Issue 5, June 1999, Pages: 525–530, SP Ahrens, MV Farmer, DL Williams, E Willoughby, K Jiang, GA Block, WH Visser and Rizatriptan Wafer Protocol 049 Study Group

    Version of Record online : 22 JUL 2009, DOI: 10.1046/j.1468-2982.1999.019005525.x

  9. Ten Years of Rizatriptan: From Development to Clinical Science and Future Directions

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue s1, February 2009, Pages: S3–S20, Richard J. Hargreaves, Chris R. Lines, Alan M. Rapoport, Tony W. Ho and Fred D. Sheftell

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1526-4610.2008.01335.x

  10. A Double-Blind, Placebo-Controlled Evaluation of the Effect of Oral Doses of Rizatriptan 10 mg on Oral Contraceptive Pharmacokinetics in Healthy Female Volunteers

    The Journal of Clinical Pharmacology

    Volume 40, Issue 3, March 2000, Pages: 309–315, Craig R. Shadle, Guanghan Liu and Michael R. Goldberg

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700022008865

  11. Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo-Controlled, Outpatient Study

    Headache: The Journal of Head and Face Pain

    Volume 38, Issue 4, April 1998, Pages: 281–287, Judith Teall, Michael Tuchman, Neal Cutler, Michael Gross, Ernest Willoughby, Betty Smith, Kai Jiang, Scott Reines, Gilbert Block and Rizatriptan 022 Study Group

    Version of Record online : 5 JUN 2003, DOI: 10.1046/j.1526-4610.1998.3804281.x

  12. You have free access to this content
    POSTER SESSION II K: Triptans

    Cephalalgia

    Volume 21, Issue 4, May 2001, Pages: 405–432,

    Version of Record online : 22 JUL 2009, DOI: 10.1046/j.1468-2982.2001.00024.x

  13. Sumatriptan (oral route of administration) for acute migraine attacks in adults

    Intervention Review

    The Cochrane Library

    Christopher J Derry, Sheena Derry and R Andrew Moore

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD008615.pub2

  14. Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of Migraine

    Headache: The Journal of Head and Face Pain

    Volume 38, Issue 10, November 1998, Pages: 748–755, Peer Tfelt-Hansen, Judith Teall, Francisco Rodriguez, Mario Giacovazzo, Jose Paz, William Malbecq, Gilbert A. Block, Scott A. Reines and W. Hester Visser

    Version of Record online : 31 MAY 2002, DOI: 10.1046/j.1526-4610.1998.3810748.x

  15. Pharmacologic Profile and Clinical Efficacy of Rizatriptan

    Headache: The Journal of Head and Face Pain

    Volume 39, Issue s1, January 1999, Pages: S9–S15, Richard B. Lipton

    Version of Record online : 14 JAN 2004, DOI: 10.1111/j.1526-4610.1999.00003.x

  16. Current and Emerging Second-Generation Triptans in Acute Migraine Therapy: A Comparative Review

    The Journal of Clinical Pharmacology

    Volume 40, Issue 7, July 2000, Pages: 687–700, Dr. Dirk Deleu and Dr. Yolande Hanssens

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700022009431

  17. Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females

    Biopharmaceutics & Drug Disposition

    Volume 19, Issue 9, December 1998, Pages: 577–581, Yih Lee, Susan J. Ermlich, Andrew T. Sterrett, Michael R. Goldberg, Robert A. Blum, Mary J. Brucker, Debra A. McLoughlin, Timothy V. Olah, Jamie Zhao and J. Douglas Rogers

    Version of Record online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-081X(199812)19:9<577::AID-BDD136>3.0.CO;2-W

  18. Annual Meeting Program Abstracts

    Headache: The Journal of Head and Face Pain

    Volume 43, Issue 5, May 2003, Pages: 509–592,

    Version of Record online : 7 MAY 2003, DOI: 10.1046/j.1526-4610.2003.00100.x

  19. Safety and tolerability of rizatriptan

    Cephalalgia

    Volume 20, Issue s1, November 2000, Pages: 16–18, F Sakai

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1468-2982.2000.020s1016.x

  20. You have free access to this content
    Traditional Acupuncture in Migraine: A Controlled, Randomized Study

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 3, March 2008, Pages: 398–407, Enrico Facco, Aldo Liguori, Filomena Petti, Gastone Zanette, Flaminia Coluzzi, Marco De Nardin and Consalvo Mattia

    Version of Record online : 14 SEP 2007, DOI: 10.1111/j.1526-4610.2007.00916.x